Event

Avenda Health extends Unfold AI to intraoperative use

1 reports · 1 sources

Avenda Health has launched Surgery Mode for its prostate cancer 3D mapping platform Unfold AI, extending support originally used for preoperative decision-making into the operating room, enabling intraoperative visualization in both robotic and non-robotic surgery. New features include magnified 3D views, adjustment of the cancer estimation map to the surgical console camera angle, intraoperative viewing of MRI slices, and capsule risk scores. Avenda Health says the feature is intended to improve how surgeons use 3D AI mapping during surgery, and comes with tools to simplify case management and physician workflows. The company cites peer-reviewed research stating that Unfold AI predicts cancer spread to adjacent anatomical structures with 92% accuracy, versus 52% for MRI alone; the study also predicts it could halve positive surgical margins, thereby reducing recurrence. These effects are research predictions cited by the company, not proven clinical outcomes.